Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Sanj K Patel

CEO, Chair at Kiniksa Pharmaceuticals International, plc (KNSA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $39.4M

Reported trades

Filed Stock Type Shares Price Value Since
May 1SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 48,565 $54.02 $2.6M +47.7%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 74,635409,019 held (−15%) $50.43 $3.8M +58.2%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 113,673295,346 held (−28%) $51.47 $5.9M +55.0%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 243,59651,750 held (−82%) $52.02 $12.7M +53.4%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 51,750 $54.02 $2.8M +47.7%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 22,544 $54.01 $1.2M +47.7%
Apr 30SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 2,141 $54.01 $116K +47.7%
Apr 8SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 7,278 $50.01 $364K +59.5%
Oct 22SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 98,934134,108 held (−42%) $38.81 $3.8M +105.6%
Oct 22SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 22,314111,794 held (−17%) $39.32 $877K +102.9%
Oct 22SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 39,331111,794 held (−26%) $38.77 $1.5M +105.8%
Oct 22SEC KNSAKiniksa Pharmaceuticals International, plc Sell Plan 97,390111,794 held (−47%) $38.83 $3.8M +105.5%
  • Sell

    CEO, Chair Sanj K Patel sold $2.6M of KNSA at $54.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Sanj K Patel sold $3.8M of KNSA at $50.43 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Sanj K Patel sold $5.9M of KNSA at $51.47 — cuts the stake by 28%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Sanj K Patel sold $12.7M of KNSA at $52.02 — cuts the stake by 82%; pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Sanj K Patel sold $2.8M of KNSA at $54.02 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Sanj K Patel sold $1.2M of KNSA at $54.01 — pre-scheduled 10b5-1 plan sale.